Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Abildgaard

Showing results (91-100 of 203) with videos related to

Pageof 21
Sort By:
Thrombosis Research|January 1, 1974
Major operations, hemostatic parameters and venous thrombosisE Korvald, U Abildgaard, M K Fagerhol
Scandinavian Journal of Haematology|November 1, 1983
Simplified assay for antithrombin III activity using chromogenic peptide substrate. Manual and automated methodG Frantzen Handeland, U Abildgaard, A O Aasen
Haemostasis|January 1, 1990
Indices of hypercoagulation in cancer as compared with those in acute inflammation and acute infarctionA K Lindahl, P M Sandset, U Abildgaard
Cardiovascular Research|May 1, 1984
Distribution of myocardial blood flow and capillary diffusion capacity across the canine heart wallO Amtorp, P Eliasen, U Abildgaard, et al.
Acta Obstetricia Et Gynecologica Scandinavica|August 1, 1992
Comparison of low molecular weight heparin vs. unfractionated heparin in gynecological surgery. II: Reduced dose of low molecular weight heparinE Borstad, K Urdal, G Handeland, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 10, 1991
[Treatment of deep venous thrombosis with low molecular weight heparin (Fragmin)]A Nesvold, B Ly, U Abildgaard, et al.
Thrombosis Research|June 15, 1988
Heparin induces release of extrinsic coagulation pathway inhibitor (EPI)P M Sandset, U Abildgaard, M L Larsen
Journal of Internal Medicine|February 16, 2006
Gains and losses of warfarin therapy as performed in an anticoagulation clinicA M Njaastad, U Abildgaard, J F Lassen
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 1, 1992
The present status of tissue factor pathway inhibitorA K Lindahl, P M Sandset, U Abildgaard
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 23, 2000
[Venous thromboembolism--incidence and risk factors in Oslo]F G Strekerud, A M Johansen, U Abildgaard
Pageof 21

Showing results (91-100 of 203) with videos related to

Sort By:
Pageof 21
Thrombosis Research|January 1, 1974
Major operations, hemostatic parameters and venous thrombosisE Korvald, U Abildgaard, M K Fagerhol
Scandinavian Journal of Haematology|November 1, 1983
Simplified assay for antithrombin III activity using chromogenic peptide substrate. Manual and automated methodG Frantzen Handeland, U Abildgaard, A O Aasen
Haemostasis|January 1, 1990
Indices of hypercoagulation in cancer as compared with those in acute inflammation and acute infarctionA K Lindahl, P M Sandset, U Abildgaard
Cardiovascular Research|May 1, 1984
Distribution of myocardial blood flow and capillary diffusion capacity across the canine heart wallO Amtorp, P Eliasen, U Abildgaard, et al.
Acta Obstetricia Et Gynecologica Scandinavica|August 1, 1992
Comparison of low molecular weight heparin vs. unfractionated heparin in gynecological surgery. II: Reduced dose of low molecular weight heparinE Borstad, K Urdal, G Handeland, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 10, 1991
[Treatment of deep venous thrombosis with low molecular weight heparin (Fragmin)]A Nesvold, B Ly, U Abildgaard, et al.
Thrombosis Research|June 15, 1988
Heparin induces release of extrinsic coagulation pathway inhibitor (EPI)P M Sandset, U Abildgaard, M L Larsen
Journal of Internal Medicine|February 16, 2006
Gains and losses of warfarin therapy as performed in an anticoagulation clinicA M Njaastad, U Abildgaard, J F Lassen
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 1, 1992
The present status of tissue factor pathway inhibitorA K Lindahl, P M Sandset, U Abildgaard
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 23, 2000
[Venous thromboembolism--incidence and risk factors in Oslo]F G Strekerud, A M Johansen, U Abildgaard
Pageof 21